Brief: Acadia Pharmaceuticals Q3 EPS USD 0.42
05/11/2025 21:05
Nov 05 (Reuters) - Acadia Pharmaceuticals Q3 product sales USD 278.633 million. Q3 net income USD 71.779 million Q3 pretax profit USD 44.595 million Q3 operating expenses USD 242.877 million
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP